This goal was attained through: (1) the production of functional insulin-producing cells with enhanced protective ability against hypoxic stress in vitro; and (2) evaluation of the therapeutic impact of these cells against diabetes mellitus in vivo. The gene discussed is INS; the disease is diabetes mellitus.